|Classification and external resources|
Silicosis (previously miner's phthisis, grinder's asthma, potter's rot and other occupation-related names) is a form of occupational lung disease caused by inhalation of crystalline silica dust, and is marked by inflammation and scarring in the form of nodular lesions in the upper lobes of the lungs. It is a type of pneumoconiosis.
Silicosis (particularly the acute form) is characterized by shortness of breath, cough, fever, and cyanosis (bluish skin). It may often be misdiagnosed as pulmonary edema (fluid in the lungs), pneumonia, or tuberculosis.
Silicosis resulted in 46,000 deaths in 2013 down from 55,000 deaths in 1990.
The name silicosis (from the Latin silex, or flint) was originally used in 1870 by Achille Visconti (1836-1911), prosector in the Ospedale Maggiore of Milan. The recognition of respiratory problems from breathing in dust dates to ancient Greeks and Romans. Agricola, in the mid-16th century, wrote about lung problems from dust inhalation in miners. In 1713, Bernardino Ramazzini noted asthmatic symptoms and sand-like substances in the lungs of stone cutters. With industrialization, as opposed to hand tools, came increased production of dust. The pneumatic hammer drill was introduced in 1897 and sandblasting was introduced in about 1904, both significantly contributing to the increased prevalence of silicosis.
Classification of silicosis is made according to the disease's severity (including radiographic pattern), onset, and rapidity of progression. These include:
- Chronic simple silicosis
Usually resulting from long-term exposure (10 years or more) to relatively low concentrations of silica dust and usually appearing 10–30 years after first exposure. This is the most common type of silicosis. Patients with this type of silicosis, especially early on, may not have obvious signs or symptoms of disease, but abnormalities may be detected by x-ray. Chronic cough and exertional dyspnea are common findings. Radiographically, chronic simple silicosis reveals a profusion of small (<10 mm in diameter) opacities, typically rounded, and predominating in the upper lung zones.
- Accelerated silicosis
Silicosis that develops 5–10 years after first exposure to higher concentrations of silica dust. Symptoms and x-ray findings are similar to chronic simple silicosis, but occur earlier and tend to progress more rapidly. Patients with accelerated silicosis are at greater risk for complicated disease, including progressive massive fibrosis (PMF).
- Complicated silicosis
Silicosis can become "complicated" by the development of severe scarring (progressive massive fibrosis, or also known as conglomerate silicosis), where the small nodules gradually become confluent, reaching a size of 1 cm or greater. PMF is associated with more severe symptoms and respiratory impairment than simple disease. Silicosis can also be complicated by other lung disease, such as tuberculosis, non-tuberculous mycobacterial infection, and fungal infection, certain autoimmune diseases, and lung cancer. Complicated silicosis is more common with accelerated silicosis than with the chronic variety.
- Acute silicosis
Silicosis that develops a few weeks to 5 years after exposure to high concentrations of respirable silica dust. This is also known as silicoproteinosis. Symptoms of acute silicosis include more rapid onset of severe disabling shortness of breath, cough, weakness, and weight loss, often leading to death. The x-ray usually reveals a diffuse alveolar filling with air bronchograms, described as a ground-glass appearance, and similar to pneumonia, pulmonary edema, alveolar hemorrhage, and alveolar cell lung cancer.
Signs and symptoms
Because chronic silicosis is slow to develop, signs and symptoms may not appear until years after exposure. Signs and symptoms include:
- Dyspnea (shortness of breath) exacerbated by exertion
- Cough, often persistent and sometimes severe
- Tachypnea (rapid breathing) which is often labored
- Loss of appetite and weight loss
- Chest pain
- Gradual dark shallow rifts in nails eventually leading to cracks as protein fibers within nail beds are destroyed.
In advanced cases, the following may also occur:
Patients with silicosis are particularly susceptible to tuberculosis (TB) infection—known as silicotuberculosis. The reason for the increased risk—3 fold increased incidence—is not well understood. It is thought that silica damages pulmonary macrophages, inhibiting their ability to kill mycobacteria. Even workers with prolonged silica exposure, but without silicosis, are at a similarly increased risk for TB.
Pulmonary complications of silicosis also include Chronic Bronchitis and airflow limitation (indistinguishable from that caused by smoking), non-tuberculous Mycobacterium infection, fungal lung infection, compensatory emphysema, and pneumothorax. There are some data revealing an association between silicosis and certain autoimmune diseases, including nephritis, Scleroderma, and Systemic Lupus Erythematosus, especially in acute or accelerated silicosis.
In 1996, the International Agency for Research on Cancer (IARC) reviewed the medical data and classified crystalline silica as "carcinogenic to humans." The risk was best seen in cases with underlying silicosis, with relative risks for lung cancer of 2-4. Numerous subsequent studies have been published confirming this risk. In 2006, Pelucchi et al. concluded, "The silicosis-cancer association is now established, in agreement with other studies and meta-analysis."
When small silica dust particles are inhaled, they can embed themselves deeply into the tiny alveolar sacs and ducts in the lungs, where oxygen and carbon dioxide gases are exchanged. There, the lungs cannot clear out the dust by mucous or coughing.
When fine particles of silica dust are deposited in the lungs, macrophages that ingest the dust particles will set off an inflammation response by releasing tumor necrosis factors, interleukin-1, leukotriene B4 and other cytokines. In turn, these stimulate fibroblasts to proliferate and produce collagen around the silica particle, thus resulting in fibrosis and the formation of the nodular lesions. The inflammatory effects of crystalline silica are apparently mediated by the Nalp3 inflammasome.
Characteristic lung tissue pathology in nodular silicosis consists of fibrotic nodules with concentric "onion-skinned" arrangement of collagen fibers, central hyalinization, and a cellular peripheral zone, with lightly birefringent particles seen under polarized light. The silicotic nodule represents a specific tissue response to crystalline silica. In acute silicosis, microscopic pathology shows a periodic acid-Schiff positive alveolar exudate (alveolar lipoproteinosis) and a cellular infiltrate of the alveolar walls.
Silicon (Si) is the second most common element in the Earth's crust (oxygen is the most common). The compound silica, also known as silicon dioxide (SiO2), is formed from silicon and oxygen atoms. Since oxygen and silicon make up about 75% of the Earth, the compound silica is quite common. It is found in many rocks, such as marble, sandstone, flint and slate, and in some metallic ores. Silica can be a main component of sand. It can also be in soil, mortar, plaster, and shingles. The cutting, breaking, crushing, drilling, grinding, or abrasive blasting of these materials may produce fine silica dust.
Silica occurs in 3 forms: crystalline, microcrystalline (or cryptocrystalline) and amorphous (non-crystalline). "Free" silica is composed of pure silicon dioxide, not combined with other elements, whereas silicates (e.g. talc, asbestos, and mica) are SiO2 combined with an appreciable portion of cations.
- Crystalline silica exists in 7 different forms (polymorphs), depending upon the temperature of formation. The main 3 polymorphs are quartz, cristobalite, and tridymite. Quartz is the second most common mineral in the world (next to feldspar).
- Microcrystalline silica consists of minute quartz crystals bonded together with amorphous silica. Examples include flint and chert.
- Amorphous silica consists of kieselgur (diatomite), from the skeletons of diatoms, and vitreous silica, produced by heating and then rapid cooling of crystalline silica. Amorphous silica is less toxic than crystalline, but not biologically inert, and diatomite, when heated, can convert to tridymite or cristobalite.
Silica flour is nearly pure SiO2 finely ground. Silica flour has been used as a polisher or buffer, as well as paint extender, abrasive, and filler for cosmetics. Silica flour has been associated with all types of silicosis, including acute silicosis.
There are three key elements to the diagnosis of silicosis. First, the patient history should reveal exposure to sufficient silica dust to cause this illness. Second, chest imaging (usually chest x-ray) that reveals findings consistent with silicosis. Third, there are no underlying illnesses that are more likely to be causing the abnormalities. Physical examination is usually unremarkable unless there is complicated disease. Also, the examination findings are not specific for silicosis. Pulmonary function testing may reveal airflow limitation, restrictive defects, reduced diffusion capacity, mixed defects, or may be normal (especially without complicated disease). Most cases of silicosis do not require tissue biopsy for diagnosis, but this may be necessary in some cases, primarily to exclude other conditions.
For uncomplicated silicosis, chest x-ray will confirm the presence of small (< 10 mm) nodules in the lungs, especially in the upper lung zones. Using the ILO classification system, these are of profusion 1/0 or greater and shape/size "p", "q", or "r". Lung zone involvement and profusion increases with disease progression. In advanced cases of silicosis, large opacity (> 1 cm) occurs from coalescence of small opacities, particularly in the upper lung zones. With retraction of the lung tissue, there is compensatory emphysema. Enlargement of the hilum is common with chronic and accelerated silicosis. In about 5-10% of cases, the nodes will calcify circumferentially, producing so-called "eggshell" calcification. This finding is not pathognomonic (diagnostic) of silicosis. In some cases, the pulmonary nodules may also become calcified.
A computed tomography or CT scan can also provide a mode detailed analysis of the lungs, and can reveal cavitation due to concomitant mycobacterial infection.
The best way to prevent silicosis is to identify work-place activities that produce respirable crystalline silica dust and then to eliminate or control the dust ("primary prevention"). Water spray is often used where dust emanates. Dust can also be controlled through dry air filtering.
Silicosis is an irreversible condition with no cure. Treatment options currently focus on alleviating the symptoms and preventing complications. These include:
- Stopping further exposure to silica and other lung irritants, including tobacco smoking.
- Cough suppressants.
- Antibiotics for bacterial lung infection.
- TB prophylaxis for those with positive tuberculin skin test or IGRA blood test.
- Prolonged anti-tuberculosis (multi-drug regimen) for those with active TB.
- Chest physiotherapy to help the bronchial drainage of mucus.
- Oxygen administration to treat hypoxemia, if present.
- Bronchodilators to facilitate breathing.
- Lung transplantation to replace the damaged lung tissue is the most effective treatment, but is associated with severe risks of its own.
- For acute silicosis, bronchoalveolar lavage may alleviate symptoms, but does not decrease overall mortality.
Experimental treatments include:
- Inhalation of powdered aluminium, d-penicillamine and polyvinyl pyridine-N-oxide.
- Corticosteroid therapy.
- The herbal extract tetrandrine may slow progression of silicosis.
Silicosis resulted in 46,000 deaths in 2013 down from 55,000 deaths in 1990.
Silicosis is the most common occupational lung disease worldwide; it occurs everywhere, but is especially common in developing countries. From 1991 to 1995, China reported more than 24,000 deaths due to silicosis each year. In the United States, it is estimated that one million-two million workers have had occupational exposure to crystalline silica dust and 59,000 of these workers will develop silicosis sometime in the course of their lives.
According to CDC data, silicosis in the United States is relatively rare. The incidence of deaths due to silicosis declined by 84% between 1968 and 1999, and only 187 deaths in 1999 had silicosis as the underlying or contributing cause. Additionally, cases of silicosis in Michigan, New Jersey, and Ohio are highly correlated to industry and occupation.
Although silicosis has been known for centuries, the industrialization of mining has led to an increase in silicosis cases. Pneumatic drilling in mines and less commonly, mining using explosives, would raise rock dust. In the United States, a 1930 epidemic of silicosis due to the construction of the Hawk's Nest Tunnel near Gauley Bridge, West Virginia caused the death of at least 400 workers. Other accounts place the mortality figure at well over 1000 workers, primarily African American transient workers from the southern United States. Workers who became ill were fired and left the region, making an exact mortality account difficult. The Hawks Nest Tunnel Disaster is known as "America's worst industrial disaster. The prevalence of silicosis led some men to grow what is called a miner's mustache, in an attempt to intercept as much dust as possible.
Chronic simple silicosis has been reported to occur from environmental exposures to silica in regions with high silica soil content and frequent dust storms.
Also, the mining establishment of Delamar Ghost Town, Nevada was ruined by a dry-mining process that produced a silicosis-causing dust. After hundreds of deaths from silicosis, the town was nicknamed The Widowmaker. The problem in those days was somewhat resolved with an addition of a nozzle to the drill which sprayed a mist of water, turning dust raised by drilling into mud, but this inhibited mining work.
Because of work-exposure to silica dust, silicosis is an occupational hazard to mining, sandblasting, quarry, ceramics and foundry workers, as well as grinders, stone cutters, refractory brick workers, tombstone workers, pottery workers, flint knappers and others. Brief or casual exposure to low levels of crystalline silica dust are said to not produce clinically significant lung disease.
Protective measures such as respirators have brought a steady decline in death rates due to silicosis in Western countries. However, this is not true of less developed countries where work conditions are poor and respiratory equipment is seldom used. For instance, life expectancy for silver miners in Potosí, Bolivia is around 40 years due to silicosis.
Recently, silicosis in Turkish denim sandblasters was detected as a new cause of silicosis due to recurring, poor working conditions.
Silicosis is seen in horses associated with inhalation of dust from certain cristobalite-containing soils in California.
Desert lung disease
A non-occupational form of silicosis has been described that is caused by long-term exposure to sand dust in desert areas, with cases reported from the Sahara, Libyan desert and the Negev. The disease is caused by deposition of this dust in the lung. Desert lung disease may be related to Al Eskan disease, a lung disorder thought to be caused by exposure to sand dust containing organic antigens, which was first diagnosed after the 1990 Gulf war. The relative importance of the silica particles themselves and the microorganisms that they carry in these health effects remains unclear.
- Chronic obstructive pulmonary disease (COPD)
- Philip D'Arcy Hart
- Hawk's Nest Incident
- John Scott Haldane
- The Citadel
- Dust pneumonia
- Pneumonoultramicroscopicsilicovolcanoconiosis - an invented synonym for silicosis "invented in imitation of polysyllabic medical terms"
|Wikimedia Commons has media related to Silicosis.|
- Imaging Findings in Silicosis by Daniel Powers, MD www.breader.com
- Risk estimates for silicosis: comparison of animal and human studies by CL Tran, BG Miller and CA Soutar. Institute of Occupational Medicine Research Report TM/05/02
- Jane A. Plant; Nick Voulvoulis; K. Vala Ragnarsdottir (13 March 2012). Pollutants, Human Health and the Environment: A Risk Based Approach. John Wiley & Sons. p. 273. ISBN 978-0-470-74261-7. Retrieved 24 August 2012.
- Derived from Gr. πνεῦμα pneúm|a (lung) + buffer vowel -o- + κόνις kóni|s (dust) + Eng. scient. suff. -osis (like in asbestosis and silicosis, see ref. 10).
- GBD 2013 Mortality and Causes of Death, Collaborators (17 December 2014). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.". Lancet. doi:10.1016/S0140-6736(14)61682-2. PMID 25530442.
- United States Bureau of Mines, "Bulletin: Volumes 476-478", U.S. G.P.O., (1995), p 63.
- Rosen G: The History of Miners' Diseases: A Medical and Social Interpretation. New York, Schuman, 1943, pp.459-476.
- "Diseases associated with exposure to silica and nonfibrous silicate minerals. Silicosis and Silicate Disease Committee". Arch. Pathol. Lab. Med. 112 (7): 673–720. July 1988. PMID 2838005.
- NIOSH Hazard Review. Health Effects of Occupational Exposure to Respirable Crystalline Silica. DHHS 2002-129. pp. 23.
- Weisman DN and Banks DE. Silicosis. In: Interstitial Lung Disease. 4th ed. London: BC Decker Inc. 2003, pp391.
- "Silicosis Fact Sheet". World Health Organization. May 2000. Archived from the original on 2007-05-10. Retrieved 2007-05-29.
- Cowie RL (November 1994). "The epidemiology of tuberculosis in gold miners with silicosis". Am. J. Respir. Crit. Care Med. 150 (5 Pt 1): 1460–2. doi:10.1164/ajrccm.150.5.7952577. PMID 7952577.
- Pelucchi C, Pira E, Piolatto G, Coggiola M, Carta P, La Vecchia C (July 2006). "Occupational silica exposure and lung cancer risk: a review of epidemiological studies 1996–2005". Ann. Oncol. 17 (7): 1039–50. doi:10.1093/annonc/mdj125. PMID 16403810.
- Cassel SL, Eisenbarth SC, Iyer SS, et al. (June 2008). "The Nalp3 inflammasome is essential for the development of silicosis". Proc. Natl. Acad. Sci. U.S.A. 105 (26): 9035–40. doi:10.1073/pnas.0803933105. PMC 2449360. PMID 18577586.
- Wagner, GR (May 1997). "Asbestosis and silicosis". Lancet 349 (9061): 1311–1315. doi:10.1016/S0140-6736(96)07336-9. PMID 9142077.
- Crystalline Silica Primer, US Dept of the Interior and US Bureau of Mines, 1992.
- CPWR-The Center for Construction Research and Training. "Work Safely with Silica: methods to control silica exposure".
- Sahu, Anand P.; Saxena, Ashok K. (October 1994). "Enhanced Translocation of Particles from Lungs by Jaggery". Environmental Health Perspectives (Environmental Health Perspectives, Vol. 102) 102 (S5): 211–214. doi:10.2307/3432088. JSTOR 3432088. PMC 1567304. PMID 7882934. Retrieved 2013-08-14.
- Chao, D.H. ; Ma, J.Y.C. ; Malanga, C.J. ; Banks, D.E. ; Hubbs, A.F. ; Rojanasakul, Y. ; Castranova, V. ; Ma, J.K.H (July 1996). "Multiple emulsion-mediated enhancement of the therapeutic effect of tetrandrine against silicosis". West Virginia University School of Pharmacy.
Previously it was shown that the action of tetrandrine is attributed to its ability to inhibit the release of reactive oxygen metabolites and inflammatory cytokines by alveolar macrophages, and that targeted delivery of tetrandrine to alveolar macrophages using a multiple emulsion system minimizes drug toxicity, maintains the drug's pharmacological activity, and enhances tetrandrine distribution in the lungs while reducing systemic drug distribution. This study provides evidence of emulsion-mediated enhancement of drug action in the lungs against silica-induced lung injury using a rat model.
- Steenland K, Goldsmith DF (November 1995). "Silica exposure and autoimmune diseases". Am. J. Ind. Med. 28 (5): 603–8. doi:10.1002/ajim.4700280505. PMID 8561170.
- "Safety and Health Topics Silica, Crystalline". Occupational Safety and Health Administration. March 2007. Retrieved 2007-05-29.
- "Ch. 2: Fatal and Nonfatal Injuries, and Selected Illnesses: Respiratory Diseases: Pneumoconioses: Silicosis". Worker Health Chartbook 2004. National Institute for Occupational Safety and Health (NIOSH). 2004. 2004-146.
- NIOSH 2004-146, Fig2-192
- NIOSH 2004-146, Fig2-190
- "The Hawks Nest Tunnel," Patricia Spangler, 2008
- Keenan, Steve (2008-04-02). "Book explores Hawks Nest tunnel history » Local News » The Fayette Tribune, Oak Hill, W.Va". Fayettetribune.com. Retrieved 2012-02-16.
- "The Hawk’s Nest Incident: America’s Worst Industrial Disaster," Dr. Martin Cherniack 1986
- Norboo T, Angchuk PT, Yahya M, et al. (May 1991). "Silicosis in a Himalayan village population: role of environmental dust". Thorax 46 (5): 341–3. doi:10.1136/thx.46.5.341. PMC 463131. PMID 2068689.
- "Adverse effects of crystalline silica exposure. American Thoracic Society Committee of the Scientific Assembly on Environmental and Occupational Health". Am. J. Respir. Crit. Care Med. 155 (2): 761–8. February 1997. doi:10.1164/ajrccm.155.2.9032226. PMID 9032226.
- Denim sandblasters contract fatal silicosis in illegal workshops
- Art Gallery of NSW: Noel Couniham Collection
- Hawass ND (September 1987). "An association between 'desert lung' and cataract—a new syndrome". Br J Ophthalmol 71 (9): 694–7. doi:10.1136/bjo.71.9.694. PMC 1041277. PMID 3663563.
- Nouh MS (1989). "Is the desert lung syndrome (nonoccupational dust pneumoconiosis) a variant of pulmonary alveolar microlithiasis? Report of 4 cases with review of the literature". Respiration 55 (2): 122–6. doi:10.1159/000195715. PMID 2549601.
- Korényi-Both AL, Korényi-Both AL, Molnár AC, Fidelus-Gort R (September 1992). "Al Eskan disease: Desert Storm pneumonitis". Mil Med 157 (9): 452–62. PMID 1333577.
- Griffin DW (July 2007). "Atmospheric movement of microorganisms in clouds of desert dust and implications for human health". Clin. Microbiol. Rev. 20 (3): 459–77, table of contents. doi:10.1128/CMR.00039-06. PMC 1932751. PMID 17630335.